BHVN20261218C20
BHVN Dec 18 2026 20.00 Call (BHVN261218C00020000)
option OPRA

Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.